Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Foster

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 30, 2018
Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkersBright Nsokolo, Anne Kanunga, Edford Sinkala, et al.
Lancet (London, England)|December 22, 2022
Deaths from alcohol-related liver disease in the UK: an escalating tragedyMichael E D Allison, Julia Verne, William Bernal, et al.
Open Forum Infectious Diseases|February 17, 2018
Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 StudiesJason Grebely, Jordan J Feld, David Wyles, et al.
Psychoneuroendocrinology|December 21, 2018
Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndromeAlice Russell, Nilay Hepgul, Naghmeh Nikkheslat, et al.
Lancet (London, England)|December 1, 2014
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitisRoger Williams, Richard Aspinall, Mark Bellis, et al.
Journal of Clinical Gastroenterology|February 8, 2014
World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013Muhammed Umar, Aamir G Khan, Zaigham Abbas, et al.
Lancet (London, England)|December 25, 2015
Implementation of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Kathryn Ashton, Richard Aspinall, et al.
Blood|June 17, 2010
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panelVito Di Marco, Marcello Capra, Emanuele Angelucci, et al.
The International Journal on Drug Policy|July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugsJason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
Lancet (London, England)|December 20, 2016
New metrics for the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Richard Aspinall, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Transactions of the Royal Society of Tropical Medicine and Hygiene|January 30, 2018
Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkersBright Nsokolo, Anne Kanunga, Edford Sinkala, et al.
Lancet (London, England)|December 22, 2022
Deaths from alcohol-related liver disease in the UK: an escalating tragedyMichael E D Allison, Julia Verne, William Bernal, et al.
Open Forum Infectious Diseases|February 17, 2018
Sofosbuvir-Based Direct-Acting Antiviral Therapies for HCV in People Receiving Opioid Substitution Therapy: An Analysis of Phase 3 StudiesJason Grebely, Jordan J Feld, David Wyles, et al.
Psychoneuroendocrinology|December 21, 2018
Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndromeAlice Russell, Nilay Hepgul, Naghmeh Nikkheslat, et al.
Lancet (London, England)|December 1, 2014
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitisRoger Williams, Richard Aspinall, Mark Bellis, et al.
Journal of Clinical Gastroenterology|February 8, 2014
World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013Muhammed Umar, Aamir G Khan, Zaigham Abbas, et al.
Lancet (London, England)|December 25, 2015
Implementation of the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Kathryn Ashton, Richard Aspinall, et al.
Blood|June 17, 2010
Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panelVito Di Marco, Marcello Capra, Emanuele Angelucci, et al.
The International Journal on Drug Policy|July 8, 2017
Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugsJason Grebely, Julie Bruneau, Jeffrey V Lazarus, et al.
Lancet (London, England)|December 20, 2016
New metrics for the Lancet Standing Commission on Liver Disease in the UKRoger Williams, Graeme Alexander, Richard Aspinall, et al.
Pageof 5